ESTRO35 Programme Book

MONDAY 2 MAY 2016

16:55 > Heterogeneous FDG-guided dose escalation of locally advanced NSCLC, the NARLAL2 phase III trial D.S. Moeller (Denmark), L. Hoffmann, C.M. Lutz, T.B. Nielsen, C. Brink, A.L. Appelt, M.D. Lund, M.S. Nielsen, W. Ottosson, A.A. Khalil, M.M. Knap, O. Hansen, T. Schytte

OC-0544

17:05 > Results of a national audit of IMRT and VMAT patient QA

E. Seravalli (The Netherlands), A.C. Houweling, M.P.R. Van Gellekom, J. Kaas, M. Kuik, E.A. Loeff, T.A. Raaben, J.A. De Pooter, J.H.W. De Vries, J.B. Van de Kamer

OC-0545

17:15 > The development of proton-beam grid therapy (PBGT) T. Henry (Sweden), A. Valdman, A. Siegbahn

OC-0546

17:25 > Towards Portal Dosimetry for the MR-linac: back-projection algorithm in the presence of MRI scanner I. Torres Xirau (The Netherlands), R. Rozendaal, I. Olaciregui-Ruiz, P. Gonzalez, U. Van der Heide, J.J. Sonke, A. Mans 17:35 > Hyperthermia treatment planning in the pelvis using thermophysical fluid modelling of the bladder

OC-0547

G. Schooneveldt (The Netherlands), H.P. Kok, E.D. Geijsen, A. Bakker, E. Balidemaj, J.J.M.C.H. De la Rosette, M.C.C.M. Hulshof, T.M. De Reijke, J. Crezee

OC-0548

Proffered Papers PHYSICS 14: TREATMENT PLANNING: APPLICATIONS II 16:45 - 17:45 | ROOM 500 Chair: M. Tenhunen (Finland) Chair: E. Moretti (Italy)

16:45 > The effects of a magnetic field and real-time tumor tracking on lung stereotactic body radiotherapy M.J. Menten (UK), M.F. Fast, S. Nill, C.P. Kamerling, F. McDonald, U. Oelfke 16:55 > Investigation of magnetic field effects for the treatment planning of lung cancer O. Schrenk (Germany), C.K. Spindeldreier, A. Pfaffenberger 17:05 > Advantage of IMPT over IMRT in treatment of gynaecological cancer with para-aortic nodal involvement M. Van de Sande (The Netherlands), C.L. Creutzberg, S. Van de Water, A.W. Sharfo, M.S. Hoogeman

OC-0549

OC-0550

OC-0551

SCIENTIFIC PROGRAMME | PROGRAMME AND EXHIBITION GUIDE

145